2026 NPPES data Optometrist NPI 1124154505 O.D.
Verify on CMS →

MARK DAVIS, O.D.

Optometrist in BOAZ, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
395
Medicare Part D claims · 112 beneficiaries · Optometrist avg: 257
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.4514/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$44.68
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK DAVIS, O.D. reported a CMS MIPS final score of 82.4514/100 — below the 83.1 national average — and filed 395 Medicare Part D claims in 2023.

82.4514/100
MIPS score · -1 vs avg
395
Part D claims, 2023
49%
generic prescribing
$44.68
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK DAVIS, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about MARK DAVIS, O.D.?

Near national average

NPI registry status

Active

Issued 02/27/2007

NPI 1124154505

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

395 54% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

82.4514/100 0.6485999999999876% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Alabama

How Optometrist compares to other specialties among Alabama providers

Alabama providers

Optometrist share within Alabama

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Alabama

Medicare quality performance — MIPS

MARK DAVIS, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

Near national average
MIPS Final Score
82.4514/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 82.4514/100 vs national avg 83.1

0%100%National avg83%82.5%
MIPS final score (Optometrist) — 82.4514/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK DAVIS, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 510 N MAIN ST, BOAZ, AL, 35957, with a listed phone of (256) 593-1986. NPI 1124154505 was issued on 02/27/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DAVIS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 395 prescription claims written by this provider, covering 112 Medicare beneficiaries and totaling roughly $32K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.4514/100 for the 2023 performance year (Quality 64.9028), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

510 N MAIN ST
BOAZ, AL 35957

Provider Details

NPI 1124154505
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 02/27/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.4514
Final Score
Avg: 83.1
64.9028
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK DAVIS, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$45

Largest payer

Astellas Pharma US Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

MARK DAVIS, O.D. — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 395 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

395
Total Claims
$32K
Total Drug Cost
112
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
716
Total Day Supply
19,846
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$24K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
75.2 years
Avg HCC Risk Score
0.98
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK DAVIS, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
178
Timolol Maleate
75
Cyclosporine
24
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
14
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How MARK DAVIS, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

MARK DAVIS, O.D.'s 395 claims are above the specialty average of 257.

Nearby Optometrist Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as DAVIS.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK DAVIS, O.D.'s specialty?
MARK DAVIS, O.D. specializes in Optometrist and practices in BOAZ, Alabama. Credentials: O.D..
How much does MARK DAVIS, O.D. prescribe under Medicare Part D?
In 2023, MARK DAVIS, O.D. wrote 395 Medicare Part D claims totaling $32K in drug costs for 112 beneficiaries.
What is MARK DAVIS, O.D.'s Medicare quality score?
MARK DAVIS, O.D. has a CMS MIPS Final Score of 82.4514/100 (Quality: 64.9028). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK DAVIS, O.D. located?
MARK DAVIS, O.D. is located at 510 N MAIN ST, BOAZ, AL, 35957. Phone: (256) 593-1986.
What is MARK DAVIS, O.D.'s NPI number?
MARK DAVIS, O.D.'s National Provider Identifier (NPI) is 1124154505, issued on 02/27/2007.
Does MARK DAVIS, O.D. prescribe more brand-name or generic drugs?
MARK DAVIS, O.D.'s prescribing is 51% brand-name and 49% generic drugs by claim count, with $24K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does MARK DAVIS, O.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK DAVIS, O.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Cyclosporine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK DAVIS, O.D. accept Medicare?
MARK DAVIS, O.D. appears in CMS Medicare data with 395 Part D claims and 112 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK DAVIS, O.D.'s credentials?
MARK DAVIS, O.D.'s NPI is 1124154505 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology